Inventor · disambiguated record
Craig A. Dunbar
Also filed as: DUNBAR CRAIG A · DUNBAR CRAIG ANTONY
9 granted patents·11 pending applications·110 citations·filing 2011–2025
87Inventor score
Files withTARVEDA THERAPEUTICS INC8CYCLERION THERAPEUTICS INC3PLACON THERAPEUTICS INC3VERTEX PHARMA2ALARGOVA ROSSITZA GUEORGUIEVA1
Top patents by PatentIndex Score
20 records- 0197US10058546B2Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereofVERTEX PHARMA·Filed 2016·Granted Aug 28, 2018·28 cites·14 claims
- 0295US9012496B2Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereofVertex Pharmaceuticals Incorported·Filed 2013·Granted Apr 21, 2015·63 cites·19 claims
- 0388US9556214B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2013·Granted Jan 31, 2017·7 cites·2 claims
- 0487US9750818B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·6 cites·2 claims
- 0586US10624967B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·8 claims
- 0682US10322191B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·5 claims
- 0782US2024293324A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0881US2025017862A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0979US10111853B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·1 cites·19 claims
- 1070US2025255821A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1164US11458206B2Targeted conjugates and particles and formulations thereofTVA ABC LLC·Filed 2020·Granted Oct 4, 2022·0 cites·6 claims
- 1263US2019015378A1Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1362US2016166715A1Nanoparticle Diagnostic and Methods for Treating DiseaseTARVEDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1461US9480657B2Cabazitaxel-platinum nanoparticles and methods of using sameTARVEDA THERAPEUTICS INC·Filed 2014·Granted Nov 1, 2016·0 cites·13 claims
- 1561US2019231906A1Nanoparticle diagnostic and methods for treating diseaseTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1656US2015182517A1Pharmaceutical Compositions of (R)-1-(2,2-Difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and Administration ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 1741US2019125888A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1840US2014088066A1Platinum compounds, compositions and methods for the treatment of cancerBLEND THERAPEUTICS·Filed 2013·Application pending·0 cites
- 1938US2017151339A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2036US2012046330A1Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereofALARGOVA ROSSITZA GUEORGUIEVA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig A. Dunbar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →